News‎ > ‎News archive‎ > ‎

Survey following RPMI shortage and controversy of risks associated with HES

posted 18 Dec 2013, 01:53 by Eoin McGrath   [ updated 9 Jul 2015, 01:01 ]
Survey closed

The EBMT through JACIE and the Cell Processing Committee has received information from a number of sources about a shortage of and/or conditions of use for ancillary materials used for cell processing (see examples below).
 
The FACT-JACIE standards provide rules and guidance for the validation and use of ancillary material, and so we wish to know more about the experience of European cell processing facilities and academic Advanced Therapy Medicinal Product (ATMP) manufacturers.

We would appreciate if you could take a few minutes to report on your experience since January 1st, 2010. Answering the questionnaire should take no more than 15 minutes.

Note that if you experienced a shortage of more than one material since 2010, you should complete a survey for each one.

The closing date was Wednesday 21 January 2013.
Comments